Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 75,802
  • Shares Outstanding, K 1,516,035
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.13
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings -0.01 on 06/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.045 unch
on 10/15/19
0.100 -55.00%
on 09/24/19
-0.055 (-55.00%)
since 09/13/19
3-Month
0.045 unch
on 10/15/19
0.135 -66.67%
on 07/24/19
-0.085 (-65.38%)
since 07/15/19
52-Week
0.045 unch
on 10/15/19
0.740 -93.92%
on 10/16/18
-0.685 (-93.84%)
since 10/15/18

Most Recent Stories

More News
FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") today announced the appointment of former U.S. congressman Stephen Buyer to the Company's Board of Directors. The Company...

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
FSD Pharma Closes First Tranche of Private Placement at $4.58 Million, Extends Offering

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") is pleased to provide an update on its previously announced private placement of its class B subordinate voting shares ("Shares")...

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
InvestmentPitch Media Video Discusses FSD Pharma's LOI with World Class Extractions Creating JV to Build and Operate Cannabis Extraction/Processing Facility in Cobourg, Ontario - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - FSD Pharma Inc. (CSE: HUGE) (FSE: 0K9) (OTCQB: FSDDF), through its wholly-owned subsidiary FV Pharma, has signed a letter of intent...

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
PUMP.CN : 0.060 (unch)
FSD Pharma Signs LOI to Establish Joint Venture with World-Class Extractions to Deploy Full Extraction Processing Center

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) ("FSD Pharma", "FSD" or "the Company") today announced the signing of a letter of intent ("LOI") to establish a joint venture (the "Joint Venture") with...

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
PUMP.CN : 0.060 (unch)
FSD Pharma Signs LOI to Establish Joint Venture with World-Class Extractions to Deploy Full Extraction Processing Center

- Joint Venture to develop, manage and operate cannabis extraction and processing center at FSD Pharma Facility in Cobourg, Ontario -

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
PUMP.CN : 0.060 (unch)
FSD Pharma Announces Private Placement

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") is pleased to announce that the Company has launched a private placement of up to US$5 million of its class B subordinate...

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
Codebase Subsidiary, Code Cannabis Investments Appoints Mr. Zach Stadnyk, President & CEO

Former Supreme Cannabis Company and FSD Pharma Management to Lead Growth and Development of Early Stage Investment Portfolio

CODE.CN : 0.025 (-16.67%)
BKLLF : 0.0251 (+19.52%)
HUGE.CN : 0.045 (-10.00%)
TGIF.CN : 0.265 (+17.78%)
FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") today announced the launch of its online ordering system for the direct fulfillment of medicinal cannabis orders. Through...

HUGE.CN : 0.045 (-10.00%)
FSDDF : 0.0410 (-2.15%)
InvestmentPitch Media Video Discusses Canntab's Receipt of Initial Indication of Patentability for Immediate Release Cannabidiol Formulation - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - August 16, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in cannabinoid and terpene blends in hard pill form for...

PILL.CN : 0.610 (+38.64%)
CTABF : 0.3700 (+0.41%)
HUGE.CN : 0.045 (-10.00%)
InvestmentPitch Media Video Discusses Canntab's Update of Significant Developments Including Hemp Cultivation and Gel Capsule Manufacturing - Video Available on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - August 1, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene...

PILL.CN : 0.610 (+38.64%)
CTABF : 0.3700 (+0.41%)
HUGE.CN : 0.045 (-10.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.058
1st Resistance Point 0.052
Last Price 0.045
1st Support Level 0.042
2nd Support Level 0.038

See More

52-Week High 0.740
Fibonacci 61.8% 0.475
Fibonacci 50% 0.393
Fibonacci 38.2% 0.310
Last Price 0.045
52-Week Low 0.045

See More

Business Summary

FSD Pharma Inc is a publicly traded company, through its wholly-owned subsidiary holds an Access to Cannabis for Medical Purposes Regulation license to cultivate cannabis. It is engaged in the production and sale of medical cannabis. All of the company's operations are situated in Canada.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar